Table 4.
Protein | Alberti algorithm | PAPA analysis | Disease | ||
---|---|---|---|---|---|
PrLD Ranka | PrLD amino acids | PAPA score | Highest scoring segment (isoform)b | ||
TDP-43 | 43 | 277–414 | 0.042 | 339–414 | ALS, FTLD |
FUS | 12 | 1–237 | 0.109 | 21–121 (2) | ALS, FTLD |
TAF15 | 22 | 1–152 | 0.127 | 12–92 (2) | ALS, FTLD |
EWSR1 | 25 | 1–280 | 0.057 | 194–274 (1) | ALS, FTLD |
hnRNPA2B1 | 32 | 197–353 | 0.043c | 241–321 (A2) | IBMPFD |
hnRNPA1 | 38 | 186–372 | 0.093d | 257–337 (b) | ALS, IBMPFD |
TIA1 | 53 | 292–386 | 0.131 | 269–349 (1) | Welander distal myopathy |
aPrLD rank among the human genome [21]
bSome of the proteins have multiple isoforms that differ either in their PAPA scores or the exact location of the highest scoring region. Shown are the amino acid positions for the highest scoring segments from the highest scoring isoform, with the isoform indicated in parentheses
cThe PAPA score for the disease-associated mutant is 0.088
d PAPA score for Isoform B, the highest scoring isoform. hnRNPA1 has two isoforms with substantially different PAPA scores. The IBMPFD-associated mutation increases the PAPA score of Isoform B to 0.125. Isoform A scores 0.041, but the IBMPFD-associated mutation increases the PAPA score to 0.087